Received Nov 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | UNK | — | OT |
Contracted Covid-19 in 2022 after having received the Pfizer Covid vaccine; Contracted Covid-19 in 2022 after having received the Pfizer Covid vaccine; This is a spontaneous report received from a Consumer or other non HCP. Other Case identifier(s): AE-00243299 (Moderna). A patient (age and gender not provided) received BNT162b2 (BNT162B2 NOS), in 2021 as dose number unknown, single (Batch/Lot number: unknown) intramuscular for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "Contracted Covid-19 in 2022 after having received the Pfizer Covid vaccine". Clinical course: Patient reported that they contracted Covid-19 in 2022 after having received the Pfizer Covid vaccine. They believe it was after the Pfizer actually and stated received the Pfizer vaccine in 2021 and contracted Covid in 2022. It was not close to the time received the vaccine at all, so it was just it might have even been in 2022 got it, so know there was some distance between the vaccine and when they got it. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.
Medical History/Concurrent Conditions: Asthma